Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Post by Maynaizeon Nov 24, 2017 12:18pm
622 Views
Post# 27025839

TMX Group Provides Update Regarding Regulatory Engagement

TMX Group Provides Update Regarding Regulatory Engagement

TORONTO, Nov. 24, 2017 /CNW/ - TMX Group, owner and operator of CDS, Canada's equities and fixed income clearing house, today provided an update on the engagement with the Canadian Securities Administrators (CSA), an umbrella organization of Canada's provincial and territorial securities regulators, regarding the clearing of securities of issuers with marijuana-related activities in the U.S. This is a complex matter which touches multiple aspects of Canada's capital market system, and as such requires close examination and careful consideration.

 

CDS continues to work with the CSA and exchanges to arrive at a solution that will clarify this matter for issuers, investors, participants and the public. This solution will be founded on each exchange's role in applying listing requirements, including exchange rules related to issuers' compliance with applicable laws. We will communicate more on this as soon as we can. In the meantime, there is no CDS ban on the clearing of securities of issuers with marijuana-related activities in the U.S.

https://www.newswire.ca/news-releases/tmx-group-provides-update-regarding-regulatory-engagement-659732023.html


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities